Subramanian, C <br/><br/>
Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)  Dec 2017 
 - 1003-1011 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5586 
<br/><br/><label>Standard No.: </label>10.1016/j.neo.2017.09.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Biomarkers<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>Cell Self Renewal--drug effects<br/>Cell Survival--drug effects<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm<br/>Gene Expression Regulation, Neoplastic<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Mice<br/>MicroRNAs--genetics<br/>Neoplastic Stem Cells--drug effects<br/>Protein Interaction Domains and Motifs--drug effects<br/>Signal Transduction<br/>Squamous Cell Carcinoma of Head and Neck<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays